Web Results

en.wikipedia.org/wiki/GeoVax

GeoVax is currently conducting multiple site Phase 2 Human clinical trials for HIV /AIDS preventative vaccine products following successful completion of multiple ...

seekingalpha.com/article/1842902-why-geovax-is-different-in-the-hiv-aids-vaccine-space

Editors' Note: This article covers a micro-cap stock. Please be aware of the risks associated with these stocks.) The Unique Preventive and Therapeutic HIV Vac.

www.geovax.com/publications.html

The Immune Space: A Concept and Template for Rationalizing Vaccine ... by a repeated dose SIVsmE660 challenge despite different immune responses.

www.geovax.com

Aids Vaccine Research - GeoVax, Inc. ... GeoVax HIV AIDS Vaccines ... cancer types in combination with other approaches to achieve a high cure rate.

www.geovax.com/investors.html

Recent entry into high-profile Zika vaccine space with multiple collaborators ... vaccine candidate for prevention of HIV infection in the developed world (HIV ...

www.pharmavoice.com/article/2016-05-hiv

There has been remarkable progress made against HIV / AIDS, in which the disease ... HIV is very different from most other vaccine-preventable viral diseases. .... GeoVax is also researching this technology in the immune-oncology space for ...

investorshub.advfn.com/GeoVax-Labs-Inc-GOVX-871

https://www.geovax.com/the-need-for-an-hiv-aids-vaccine.html ... Recent entry into high-profile Zika vaccine space with multiple collaborators ... A Smyrna- based developer of vaccines against Zika, Ebola, HIV and other infectious diseases has ...

www.science20.com/erin039s_spin/will_hiv_vaccine_succeed_where_others_have_failed

Dec 8, 2008 ... Since the 80's, as the awareness of HIV has increased exponentially, scientists have struggled for a vaccine to quell the rising number of ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4208609

AIDS Research and Human Retroviruses ... 10GeoVax Inc., Smyrna, Georgia. ... This is especially true for diseases such as dengue, HIV, and tuberculosis where there ... This “immune space” approach may also be applicable to other vaccine ...